title: Blocking endogenous opioids during development--do we understand the consequences?
authors: School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, South Australia 5001, Australia. jason.white@unisa.edu.au
authors: Jason
authors: J
authors: White
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects*; D002047:Buprenorphine / Q000009:adverse effects; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D006801:Humans; D008691:Methadone / Q000009:adverse effects; D009271:Naltrexone / Q000009:adverse effects / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D009294:Narcotics / Q000009:adverse effects; D058850:Opiate Substitution Treatment / Q000009:adverse effects; D009293:Opioid-Related Disorders / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone